Genprex Receives U.S. FDA Fast Track Designation for REQORSA(TM) Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer
January 3, 2022
Host Jon Najarian interviews CEO, Richard Danforth, who elaborates on the alert system that Genasys has created.